Powell's speech will be closely watched for signs of a slowdown in the pace of interest rate hikes by the central bank, as well as to asses...

The ‘Eisai’ and ‘Biogen’ drug slowed cognitive decline in study participants, but many experienced brain bleeds, swelling, or other side ef...

Shares of the Cupertino, California tech giant lost 2.6% and weighed heavily on the benchmark S&P 500 index as worker unrest at the world's...

The Dow Jones Industrial Average fell 71.1 points, or 0.21%, at the open to 34,275.91

The Dow Jones Industrial Average was down 7.84 points, or 0.02%, at 33,740.02

Biogen's $56,000 per year treatment price for an average weight person was seen as a significant cost burden on Medicare, which covers more...

In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squ...

Data showed fewer weekly jobless claims pointed to a steady recovery in the labor market.

The Nasdaq gained the most among the three major indexes, while the bellwether S&P 500 squeaked its way to a second straight record closing...

Investors remained on the fence ahead of key inflation data later this week.

As a part of the deal to research and develop monoclonal antibody treatments for influenza and other respiratory illnesses, GSK will make a...

A panel of outside experts meets Friday to advise the Food and Drug Administration on aducanumab, a drug from Cambridge, Massachusetts-base...

Drug major Glenmark Pharma said it has received final approval from the US health regulator for Dimethyl Fumarate delayed-release capsules,...

The Nikkei share average rose 1.52 per cent to 19,429.44 after three straight sessions of losses.

Buffett’s company has been trimming its stakes in some major lenders to try to avoid crossing a 10% ownership threshold that often draws re...

These are generic version of Tecfidera Capsules, 120 mg and 240 mg, of Biogen Inc.

As uncomfortable as it will be for the drugmakers, it may not result in much lasting damage.